Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Financial Guidance
For the full year 2024, the Company revised its expectations for an adjusted EPS(1) range of $2.45 to $2.65. This contemplates the Company's current outlook that 2024 sales will be consistent versus prior year. At the midpoint, this revised guidance represents a 6% increase in adjusted EPS(1) from the prior year.
Posted In: TPX